Crown Bioscience

Crown Bioscience company information, Employees & Contact Information

Explore related pages

Related company profiles:

Crown Bioscience, a JSR Life Sciences company, is a global contract research organization (CRO) dedicated to accelerating drug discovery and development in oncology and immuno-oncology. We partner with biotech and pharmaceutical companies to provide innovative, tailored solutions spanning preclinical research, translational platforms, and clinical trial support. With the world’s largest commercially available patient-derived xenograft (PDX) collection and approximately 1,000 tumor organoid models powered by Hubrecht Organoid Technology, we offer unparalleled insights across 35 cancer indications. Our expertise spans in vivo, in vitro, ex vivo, and in silico methods, complemented by advanced laboratory services that span the entire drug development continuum. Additionally, our extensive biobank of liquid and human biospecimens, complete with clinical histories, enhances oncology research capabilities. Operating from 11 state-of-the-art facilities across the US, Europe, and APAC, our laboratories meet the highest industry standards, including accreditation by the College of American Pathologists (CAP) and the International Organization for Standardization (ISO). To learn more, visit www.crownbio.com.

Company Details

Employees
568
Address
16550 West Bernardo Drive, Building 5,suite 525,china
Phone
(855)827-6968
Email
bu****@****io.com.
Industry
Biotechnology Research
NAICS
Research and Development in Biotechnology (except Nanobiotechnology)
HQ
San Diego, California
Looking for a particular Crown Bioscience employee's phone or email?

Crown Bioscience Questions

News

Medicines Discovery Catapult and Crown Bioscience Form Strategic Global Alliance for Radiopharmaceutical Innovation - Yahoo Finance

Medicines Discovery Catapult and Crown Bioscience Form Strategic Global Alliance for Radiopharmaceutical Innovation Yahoo Finance

Crown Bioscience Expands US Presence with New Model Development Center in Kannapolis, North Carolina - FinancialContent

Crown Bioscience Expands US Presence with New Model Development Center in Kannapolis, North Carolina FinancialContent

Crown Bioscience and NEXT Oncology Cement Partnership Extension - Business Wire

Crown Bioscience and NEXT Oncology Cement Partnership Extension Business Wire

Crown Bioscience Wins 2024 Fierce CRO Award for Excellence in Client Service and Partnership - Business Wire

Crown Bioscience Wins 2024 Fierce CRO Award for Excellence in Client Service and Partnership Business Wire

Targeting brain lesions of non-small cell lung cancer by enhancing CCL2-mediated CAR-T cell migration - Nature

Targeting brain lesions of non-small cell lung cancer by enhancing CCL2-mediated CAR-T cell migration Nature

Mainz Biomed Initiates Feasibility Phase for Non-Invasive Pancreatic Cancer Screening Test in PancAlert Project - Nasdaq

Mainz Biomed Initiates Feasibility Phase for Non-Invasive Pancreatic Cancer Screening Test in PancAlert Project Nasdaq

Crown Bioscience Strategically Strengthens Leadership Team and Names New Chief Financial Officer - PR Newswire

Crown Bioscience Strategically Strengthens Leadership Team and Names New Chief Financial Officer PR Newswire

Crown Bioscience Expands Singapore Facility with Advanced Oncology Models and Imaging Capabilities - FinancialContent

Crown Bioscience Expands Singapore Facility with Advanced Oncology Models and Imaging Capabilities FinancialContent

CrownBio Acquires OcellO B.V. to Expand Its Preclinical In Vitro Drug Development Service Offerings - Business Wire

CrownBio Acquires OcellO B.V. to Expand Its Preclinical In Vitro Drug Development Service Offerings Business Wire

Crown Bioscience Partners with CTI to Support Consulting Services in Oncology Drug Development - FinancialContent

Crown Bioscience Partners with CTI to Support Consulting Services in Oncology Drug Development FinancialContent

Crown Bioscience to Acquire Indivumed’s Service Business and Supporting Biobank - Business Wire

Crown Bioscience to Acquire Indivumed’s Service Business and Supporting Biobank Business Wire

Crown Bioscience Achieves CAP 15189 Accreditation; ISO 15189 Standard for Quality Medical Laboratory Services - FinancialContent

Crown Bioscience Achieves CAP 15189 Accreditation; ISO 15189 Standard for Quality Medical Laboratory Services FinancialContent

Crown Bioscience: First Clinical Candidate Developed Using HUB Organoids® and High Content Screening Targets Cancer Stem Cells in Solid Tumors, Published in Nature Cancer - Business Wire

Crown Bioscience: First Clinical Candidate Developed Using HUB Organoids® and High Content Screening Targets Cancer Stem Cells in Solid Tumors, Published in Nature Cancer Business Wire

Crown Bioscience Announces New Preclinical and Translational Oncology Data Across Ten Poster Presentations at AACR 2024 - FinancialContent

Crown Bioscience Announces New Preclinical and Translational Oncology Data Across Ten Poster Presentations at AACR 2024 FinancialContent

Crown Bioscience Appoints Michael Prosser as Chief Business Officer and Illustrates Further Investment in Commercial Leadership - Business Wire

Crown Bioscience Appoints Michael Prosser as Chief Business Officer and Illustrates Further Investment in Commercial Leadership Business Wire

Crown Bioscience Announces Expedited Access to Well-Established ATCC and NIH Cell Lines for Large-Scale Screening Panels - FinancialContent

Crown Bioscience Announces Expedited Access to Well-Established ATCC and NIH Cell Lines for Large-Scale Screening Panels FinancialContent

Medicines Discovery Catapult and Crown Bioscience Create Alliance for Radiopharmaceuticals - PharmTech

Medicines Discovery Catapult and Crown Bioscience Create Alliance for Radiopharmaceuticals PharmTech

Crown Bioscience launches large-scale organoid panel screening platform for accelerated preclinical oncology drug discovery - News-Medical

Crown Bioscience launches large-scale organoid panel screening platform for accelerated preclinical oncology drug discovery News-Medical

Mainz Biomed Initiates Feasibility Study of Biomarker Panel in Pancreatic Cancer Project - GlobeNewswire

Mainz Biomed Initiates Feasibility Study of Biomarker Panel in Pancreatic Cancer Project GlobeNewswire

Crown Bioscience Announces Transaction Closing of Indivumed's Service Business and Supporting Biobank - FinancialContent

Crown Bioscience Announces Transaction Closing of Indivumed's Service Business and Supporting Biobank FinancialContent

Crown Bioscience Appoints Michael Prosser as Chief Business Officer and Illustrates Further Investment in Commercial Leadership - FinancialContent

Crown Bioscience Appoints Michael Prosser as Chief Business Officer and Illustrates Further Investment in Commercial Leadership FinancialContent

Crown Bioscience enters into collaboration with Xstrahl for radiation biology research - News-Medical

Crown Bioscience enters into collaboration with Xstrahl for radiation biology research News-Medical

Oncology drug development services: an interview with Dr. Jean-Pierre Wery, President of Crown Bioscience, Inc. - News-Medical

Oncology drug development services: an interview with Dr. Jean-Pierre Wery, President of Crown Bioscience, Inc. News-Medical

PYC'S FOURTH DRUG CANDIDATE HAS DISEASE-MODIFYING POTENTIAL IN POLYCYSTIC KIDNEY DISEASE - PR Newswire

PYC'S FOURTH DRUG CANDIDATE HAS DISEASE-MODIFYING POTENTIAL IN POLYCYSTIC KIDNEY DISEASE PR Newswire

Is Boston losing its biotech crown? BIO conference takes place amidst industry fears - MassLive

Is Boston losing its biotech crown? BIO conference takes place amidst industry fears MassLive

Using radiation models to improve cancer therapies: an interview with Adrian Treverton, COO of Xstrahl and Jean-Pierre Wery, President of Crown Bioscience - News-Medical

Using radiation models to improve cancer therapies: an interview with Adrian Treverton, COO of Xstrahl and Jean-Pierre Wery, President of Crown Bioscience News-Medical

Crown Bioscience Introduces OrganoidXplore: Revolutionizing Cancer Research with Rapid Large-scale Organoid Drug Screening - Via TT

Crown Bioscience Introduces OrganoidXplore: Revolutionizing Cancer Research with Rapid Large-scale Organoid Drug Screening Via TT

AACR 2025: Crown Bioscience Unveils 3D Bone Marrow Niche In Vitro Models for Oncology Preclinical Screening in Hematological Malignancies - Via TT

AACR 2025: Crown Bioscience Unveils 3D Bone Marrow Niche In Vitro Models for Oncology Preclinical Screening in Hematological Malignancies Via TT

JSR buys up CRO Crown Biosciences in $400M deal - Fierce Biotech

JSR buys up CRO Crown Biosciences in $400M deal Fierce Biotech

NIRC lands pharmaceutical facility - theind.com

NIRC lands pharmaceutical facility theind.com

Top Crown Bioscience Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant